5-(3-Chloro-2-fluorobenzyl)-2,4-dimethoxybenzoic acid, 95.0%, 1g

4-Iodo-2-methoxy-1-nitrobenzene, 97%, 10g

4-Chloro-2-hydroxypyridine, 98.0%, 100g

(1S,4S)-5,5-Difluoro-2-azabicyclo[2.2.1]heptane hydrochloride, 98%, 1g

5-Bromo-2-(4-fluorophenyl)pyridine, 95.0%, 1g

1-(4-nitrobenzoyl)piperidine-4-carboxylic acid, 95.0%, 5g

Lead(II) chloride, min. 98%, 500 g, plastic packaging.

2,6-Bis(4-azidobenzylidene)cyclohexanone (wetted with ca. 30% Water) (unit weight on dry weight basis) [Research for Photosensitive Material]>85.0%(HPLC)5g

N-methyl-1-(5-quinolinyl)methanamine hydrochloride, 95.0%, 5g

4-Bromo-2-chlorophenol>97.0%(GC)25g

Pravastatin Sodium>98.0%(HPLC)(T)500mg

2-(Benzyloxy)-5-bromopyridine, 95.0%, 5g

4-Chloro-N-methylpyridine-2-carboxamide, 97.0%, 500g